Therapeutic Options for Achieving Realistic Management Goals in your IBS Patients: An Update for Primary Care

Gastroenterology
Curriculum:
Managing a Patient with Irritable Bowel Syndrome
Credits:
1.25 ANCC Contract Hours 1.25 AMA PRA Category 1 Credit(s)™
Launch Date:
30-Jan-18
Expiration Date:
29-Jan-19

Primary Audience:

Primary care clinicians, including physicians, physician assistants, nurse practitioners, nurses and others who diagnose, treat, and manage patients with IBS.

Relevant Terms:

Primary Care

H. Christian Weber, MD

Horst Christian Weber, MD
Course Director
Department of Medicine, Gastroenterology
Boston Medical Center
Assistant Professor of Medicine
Boston University School of Medicine
Boston, MA
 
Associated Chief and Clinical Director,
Gastroenterology and Hepatology
VA Boston Healthcare System
Jamaica Plain, MA

Dr. Weber joined the faculty of Boston University School of Medicine as Assistant Professor of Medicine in the Section of Gastroenterology in 1997. Dr. Weber is a native of Germany and graduated from Hamburg University Medical School. He completed his training in internal medicine at the University of Mainz, Germany, and at the MetroWest Medical Center in Framingham, MA, and his fellowship in gastroenterology at Georgetown University Medical Center and the National Institutes of Health. He is board-certified in gastroenterology.
 
Dr. Weber's research focuses on the biology and clinical aspects of gastrointestinal hormones. His clinical interests include obesity, gastric acid-related disorders, such as peptic ulcer disease and gastro-esophageal reflux disease (GERD), functional bowel disorders, such as irritable bowel syndrome (IBS), and genetic disorders of the gut. He is a nationally recognized authority in the field of gastrointestinal neuroendocrine tumors (NET), including Zollinger-Ellison syndrome, and has authored or co-authored numerous peer-reviewed original publications, book chapters, reviews and abstracts. Dr. Weber is a member of several professional societies including the American Gastroenterological Association (AGA) and American College of Gastroenterology (ACG) and is also member of editorial boards of several professional journals.

Albena Halpert, MD

Albena Halpert, MD
Consultant Faculty
Assistant Professor
Section of Gastroenterology
Boston University School of Medicine
Boston, MA

Dr. Halpert is a gastroenterologist at Pentucket Medical Associates in Haverhill, MA and Assistant Professor in the Section of Gastroenterology at the Boston University School of Medicine in Boston, MA.
 
Dr. Halpert received her Doctor of Medicine degree from Charles University School of Medicine in Prague, Czech Republic. She completed gastroenterology fellowships at St. Louis University in St. Louis, MO and at the Center for Functional Gastrointestinal Disorders at the University of North Carolina at Chapel Hill.
 
Dr. Halpert’s clinical and research interests include the management of functional gastrointestinal and motility disorders such as irritable bowel syndrome, dyspepsia, constipation, and fecal incontinence. Other areas of interest include antidepressant treatment in IBS, patient education and patient – physician relationship.
 
She is a member of the American Gastroenterological Association, the American College of Gastroenterology, and the International Foundation for Functional GI Disorders.
1. Identify symptom criteria for the diagnosis of irritable bowel syndrome (IBS) and its subtypes by eliciting a thorough patient history and applying clinical symptom criteria
2. Implement available screening and diagnostic tools for the diagnosis of IBS and recognize indications for referral to specialist care
3. Articulate the range of treatment options (both pharmacologic and non-pharmacologic therapies) for patients with IBS
4. Interpret consensus guidelines for the management of IBS
5. Summarize evidence-based guidelines for effective monitoring of patients with IBS
6. Establish strategies to improve communication between patients and healthcare providers concerning their symptoms of IBS and its management in order to improve outcomes

DISCLOSURE POLICY STATEMENT
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 
 
Faculty Disclosures
Dr. Christian Weber, Course Director, is a consultant for Allergan and Karos Pharmaceuticals.
 
Dr. Albena Halpert, Consultant Faculty, is a consultant for Allergan.
 
Off-Label Discussions
The unlabeled/investigational uses of commercial products will be discussed in this activity.
For IBS-D off-label discussion of probiotics, loperamide, diphenoxylate-atropine, smooth muscle antispasmodics, tricyclic antidepressants, antibiotics and bile salts (cholestyramine) will be included. For IBS-C off-label discussion of fiber supplementation, laxatives, plecanatide (CIC), antispasmodics, SSRI/SNRI and behavioral therapies.
 
Planning Committee Disclosures
 
Rachel Bereiweriso, NP, MSN, Nursing Course Advisor for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
 
Michael Burk, Senior Program Manager for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
 
Carmela Townsend, Lead Nurse Planner for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
 
Christopher Drury, consultant medical editor for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
 
Dana Frazier, Program and Grant Manager for Boston University School of Medicine's Office of Continuing Medical Education, has no financial relationships to disclose.
 
Bret Lashner, MD, Co-Course Director for Boston University School of Medicine's Office of Continuing Medical Education and Professor of Medicine at the Cleveland Clinic, has no financial relationships to disclose.
 
DISCLAIMER
THIS CONTINUING MEDICAL EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.  NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
 
ACCREDITATION STATEMENT
Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Contact Hours: 1.25, all of which are eligible for pharmacology credit.

HOW TO RECEIVE CREDIT
In order to successfully complete this activity, you are required to review the entire course content and successfully complete the post-test and evaluation. CME and CNE credit will be awarded provided a score of 70% or better is achieved. A certificate of credit will be available for immediate download to those who successfully complete the examination.
 
Release Date: 1/31/18
Expiration Date: 1/30/19
Date of Most Recent Review: Not Applicable
Program Code: E.IBS17
 
For questions about CME, please contact cme@bu.edu or www.bu.edu/cme.
To view Boston University's Privacy Policy, please see http://www.bumc.bu.edu/cme/policies/.

© Trustees of Boston University, 2018
 
COMMERCIAL SUPPORT
This continuing medical education activity is supported by independent educational grants from Allergan, Ironwood Pharmaceuticals Inc., and Salix Pharmaceuticals Inc.

COURSE VIEWING REQUIREMENTS

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
 
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above.